by Jinghong ChenWhile the Affordable Care Act took steps to reduce seniors’ share of drug bills, price increases over the past 10 years have offset expected savings, according to a new JAMA study that compared point-of-sale prices from 2010 to 2018 for orally administered anticancer drugs offered through Medicare Part D. There were 13 medications covered by Part D in 2010 and 54 in 2018
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.